QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, today reported financial results for the fiscal third quarter and nine months ended February 28, 2009. Financial results include the acquisition of Diomed assets since June 17, 2008, the date of acquisition, and the acquisition of FlowMedica assets since January 12, 2009, the date of acquisition.
